Japanese inventions

Fraunhofer IIS Introduces New Test Service and Trademark Program for xHE-AAC Audio Codec

Retrieved on: 
Tuesday, January 12, 2021
Technology, Audio, Video, Hardware, Consumer electronics, Audio codecs, Broadcast engineering, Television technology, Japanese inventions, Unified Speech and Audio Coding, High-Efficiency Advanced Audio Coding, Fraunhofer Society, Fraunhofer, Fraunhofer FDK AAC, Advanced Audio Coding

Fraunhofer IIS, an institute of Fraunhofer-Gesellschaft in Germany, has announced a new web-based test service that developers and manufacturers can use to validate their implementations of the xHE-AAC audio codec for compliance with MPEG standards.

Key Points: 
  • Fraunhofer IIS, an institute of Fraunhofer-Gesellschaft in Germany, has announced a new web-based test service that developers and manufacturers can use to validate their implementations of the xHE-AAC audio codec for compliance with MPEG standards.
  • The service, which is available exclusively at https://test.xhe-aac.com , is free to use upon registration with Fraunhofer IIS and will test both encoders and decoders.
  • Fraunhofer IIS will be licensing the use of its xHE-AAC trademark on a no-charge basis for use with products that successfully pass the test service tests.
  • Fraunhofer IIS is pleased to announce this xHE-AAC program which extends its trademark programs from MPEG-H into the AAC codec family.

MPEG LA Issues Statement Regarding CRISPR Patent Licensing

Retrieved on: 
Friday, July 26, 2019
Technology, Medical devices, Professional services, Genetics, Science, Biotechnology, Health, Other Science, Other Technology, Other Professional Services, Other Health, Legal, MPEG, MPEG LA, Broadcast engineering, Television technology, Japanese inventions, Patent, Moving Picture Experts Group

In light of questions asked of MPEG LA regarding recent events that include the announcement by The Broad Institute and MilliporeSigma to offer their own CRISPR License ( press release ), the commencement of a new patent interference proceeding by the US Patent Office set in motion by a series of patent applications filed by The University of California [ Interference No.

Key Points: 
  • In light of questions asked of MPEG LA regarding recent events that include the announcement by The Broad Institute and MilliporeSigma to offer their own CRISPR License ( press release ), the commencement of a new patent interference proceeding by the US Patent Office set in motion by a series of patent applications filed by The University of California [ Interference No.
  • Among all the parties involved in CRISPR patent licensing, MPEG LA is unique in its independence and neutrality.
  • In addition, MPEG LA has developed Increscent Therapeutics, a delivery platform for oligonucleotide therapeutics, which is available for licensing.
  • MPEG LA has operated licensing programs for a variety of technologies consisting of more than 21,000 patents in 90 countries with some 250 patent holders and more than 6,000 licensees.